•
Dec 31, 2022

Seres Therapeutics Q4 2022 Earnings Report

Total Revenue
$975K
Previous year: $7.22M
-86.5%
EPS
-$0.54
Previous year: -$0.55
-1.8%
Gross Profit
-$29K
Previous year: -$29.5M
-99.9%
Cash and Equivalents
$163M
Previous year: $180M
-9.4%
Free Cash Flow
-$56.4M
Previous year: -$53.4M
+5.4%
Total Assets
$349M
Previous year: $355M
-1.7%

Seres Therapeutics

Seres Therapeutics